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often observed in signaling pathways, consists of peptide recognition domains binding short protein
segments on the surface of their target proteins. Recent developments in experimental techniques
have uncovered many such interactions and shed new lights on their speciﬁcity. To analyze these
data, novel computational methods have been introduced that can accurately describe the speciﬁc-
ity landscape of peptide recognition domains and predict new interactions. Combining large-scale
analysis of binding speciﬁcity data with structure-based modeling can further reveal new biological
insights into the molecular recognition events underlying signaling pathways.
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The intra-cellular environment is crowded with thousands of
different proteins and other bio-molecules. Most of these bio-mol-
ecules do not work in isolation but need to interact with one an-
other to carry out their function in cellular processes [1]. An
exquisite degree of speciﬁcity is observed in these interactions.
These include transcription factors speciﬁcally recognizing DNA
stretches in gene promoter regions [2], lipid-binding proteins
selectively distinguishing between different molecules [3], or pep-
tide recognition domains (PRDs) interacting with short protein
segments present in other proteins [1]. Binding speciﬁcity is crucial
to ensure that each protein binds to its cognate ligands, with min-
imal interference from other molecules.
Peptide recognition domains are small protein domains whose
main function is to bind short linear protein segments, often ex-
pressed in disordered regions of other proteins. Some of the most
well-studied families of PRDs include SH2 [4–6], SH3 [6–9], PDZ
[10–13], WW [14,15], 14-3-3 [16], EH [17], PTB [18–20] or brom-
odomains [21]. PRDs are found in approximately 4% of human pro-
teins and are well-conserved throughout metazoans. To this list
one could further add a variety of membrane receptors such as ma-
jor histocompatibility complex or enzymes such as kinases or
phosphatases that can bind peptides as well, although they are
typically not referred to as peptide recognition domains. Interac-
tions mediated by PRDs display a high degree of selectivity byal Societies. Published by Elsevierrequiring speciﬁc sequence patterns to be present in their ligands.
For instance, class I SH3 domains bind mainly ligands containing a
[R/K]xxPxxP sequence motif. At the same time, they are character-
ized by a relatively low afﬁnity (typically around 1–10 lM). Fur-
thermore, in contrast to interactions underlying large stable
biological complexes such as the ribosome or the proteasome, they
are transient so that ligands bind and unbind rapidly (with typical
off-rates in the range of 1–10 s1). The ability of PRDs to bind tran-
siently and speciﬁcally to other proteins makes them ideal as
building blocks of scaffold proteins for assembling signaling com-
plexes or recruiting substrates for different enzymes [1]. As such,
many of these domains are found in combination with other do-
mains. For instance, the second most common domain architecture
of SH2 containing proteins is the well-known SH3–SH2–protein
tyrosine kinase combination found in proteins like ABL1 or SRC.
Determining the speciﬁc sequence patterns recognized by PRDs
is useful to help predicting and understanding their interactions,
which can elucidate their roles in signaling pathways. This goal
has driven many experimental and computational developments
in mapping PRD binding speciﬁcity over the last 20 years. Recent
technological advances have signiﬁcantly increased our ability to
characterize the speciﬁcity of PRDs by experimentally screening
larger libraries of peptides and isolating those binding to a given
PRD. The number of available crystal structures of PRDs in complex
with different ligands has also greatly increased over the last years.
This type of information was crucial to build computational models
of binding speciﬁcity, which is key to guide, reﬁne or complement
direct experimental determination of protein–protein interactions.B.V. Open access under CC BY-NC-ND license. 
Table 1
Overview of the most widely used experimental methods to investigate binding speciﬁcity of PRDs. In oriented peptide array libraries, only amino acid preferences at each
position are determined and not the exact peptide sequences.
Experimental technique Type of interactions Number of peptides that can be typically
screened
Type of output
Oriented peptide array
libraries
Non-competitive – Binding preferences at each position
Microarrays Non-competitive 101–103 Saturation curves (high afﬁnity), or binary (low afﬁnity)
SPOT Non-competitive 103–104 Interactions measured with light intensity
(semi-quantitative)
Phage display Competitive 109–1011 Set of binding peptides
Ribosome display Competitive 1012–1014 Set of binding peptides
1 As this quantity is difﬁcult to compute exactly, it has sometimes been
approximated by log2ðTÞ þ
PT
i¼1
Ka ðiÞP
j
Ka ðjÞ log2ð
KaðiÞP
j
Ka ðjÞÞ, under the assumptions tha
binding probabilities P(i) are proportional to association constants K (i).
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analyze peptide recognition domain speciﬁcity and what new bio-
logical insights can be obtained from these results. We note that
modeling binding speciﬁcity has also found widespread applica-
tions in the ﬁeld of protein–DNA and protein–RNA interactions
[2,22,23]. The computational tools used in this research area are
very similar to those developed to describe PRD speciﬁcity and ad-
vances in both ﬁelds have strongly inﬂuenced each other.
2. Experimental techniques
Analysis of PRD binding speciﬁcity relies on the availability of
experimental data. One particularly useful kind of data consists
of large datasets of peptides experimentally determined to bind
to a given domain. Table 1 summarizes some of the most widely
used experimental methods to investigate PRD speciﬁcity. Tech-
niques to screen peptide libraries with PRDs have been pioneered
in the 90s by Cantley and others with oriented peptide libraries
[24]. This technology allows for screening very large peptide li-
braries generated with solid-phase technology and incubated with
a domain of interest. In these experiments, only information about
residue preferences at each position is retrieved in general, rather
than the exact sequence of binding peptides. Another experimental
method that has been widely used to screen large numbers of pep-
tides is the SPOT technology [9,25,26]. With this technology hun-
dreds of different peptides can be spotted on a membrane sheet
with each peptide in a different spot. The peptides interacting with
a given PRD are identiﬁed by incubating a GST-fused version of the
domain. Spots with a bound domain can be detected for instance
with an anti-GST monoclonal antibody (mAB) and a horseradish
peroxidase-coupled anti-mAb antibody [26]. The ﬁnal signal of
each spot is measured as the light intensity induced by a chemilu-
minescence substrate. Oriented peptide libraries are currently
mostly used in combination with SPOT technology, by ﬁxing one
residue at one position along the peptides in each spot, while the
other positions are kept random. In this way, arrays of biased ori-
ented peptide libraries are created [27]. Protein domain micro-
arrays have been used to quantify speciﬁcity of different
domains, such as PDZ [13], SH2 and PTB domains [28]. This tech-
nology is slightly more limited in the number of peptides that
can be tested, since peptides are typically tested individually, while
the different domains are ﬁxed on a plate. However, in general it
gives more quantitative measurements than many other high-
throughput assays. In particular, Kd values can be inferred for high
afﬁnity ligands [29]. Techniques based on peptide display libraries
enable the generation of very large libraries of billions of peptides
using the transcription and translation machinery of cells or
viruses. In particular, phage display has been widely used to exper-
imentally determine PRD binding speciﬁcity [9,12,30,31]. There,
peptides are expressed on the surface of phage particles and the
whole library is incubated with the domain of interest that is typ-
ically ﬁxed on a plate. High-afﬁnity ligands are isolated by severalruns of selection (carried out by washing the plate) and ampliﬁca-
tion of the bound phage particles that will be used in the next run
[31]. The DNA of the remaining phage particles is eventually se-
quenced to determine the identity of the peptides binding to the
domain. Recent developments in DNA sequencing technologies
have signiﬁcantly increased the throughput of this method, en-
abling rapid identiﬁcation of thousands of interacting peptides in
a single screen [32,33]. Other peptide display technologies, such
as ribosome display [34] can screen even larger peptide libraries.
However, their application to PRD binding speciﬁcity has been lim-
ited to a few special cases [35]. A possible drawback of phage dis-
play technology is the competitive aspect of this assay, which
tends to favor highest-afﬁnity peptides, while biological ligands
are not necessarily optimized only for their afﬁnity. In particular,
several cases have been documented where sub-optimal afﬁnity
is required for optimal functionality [36]. Yet, the ability to sample
such a vast repertoire of sequences makes phage display technol-
ogy remarkably well suited for unbiased analysis of binding spec-
iﬁcity in PRDs.
3. Speciﬁcity landscapes
Large datasets of peptide ligands reveal key features of PRDs
that can be used to analyze their binding speciﬁcity and predict
their interactions. Speciﬁcity refers here to the ability of a PRD to
distinguish between different peptides or proteins. Highly speciﬁc
domains typically interact only with a very narrow set of proteins
and require very speciﬁc sequence patterns to be present in their
ligands. Reversely promiscuous domains bind to a wide range of
different ligands with similar probabilities. A complete description
of the binding speciﬁcity landscape of a PRD would ideally require
associating with any peptide sequence some experimentally mea-
sured numerical value, such as binding afﬁnity [23]. Then, for a set
of T different ligands, the probability P(i) for the domain to bind to
each ligand can be theoretically computed [37]. The domain spec-
iﬁcity can be numerically quantiﬁed as log2ðTÞ þ
PT
i¼1PðiÞ
log2ðPðiÞÞ,1 where
PT
i¼1PðiÞ ¼ 1. This quantity, sometimes called the
information content of the binding site [38], reaches a minimal value
(equal to 0) if the domain binds with the same probability to all li-
gands (i.e., PðiÞ ¼ 1=T) and a maximal value (equal to log2ðTÞ) if it
only binds to one of the ligands. For instance if a domain is incubated
with three ligands and binds to them with probabilities 0.9, 0.05,
0.05, respectively, the speciﬁcity is equal to 1.016, which is closer
to the maximal value of 1.585. Beyond the mathematical aspects
of deﬁning binding speciﬁcity, it is important to note that speciﬁcity
depends both on the biophysical characteristics of a domain (i.e.,
binding afﬁnity), and on the pool of ligands that the domain is ex-
posed to in a given biological context. In particular, by narrowingat
A B
C
D
Fig. 1. Evolution of binding speciﬁcity landscape descriptions. The ﬁgure illustrates
three different models (B–D) of speciﬁcity for the yeast Lsb1p SH3 domain. (A)
Peptides binding to Lsb1p SH3 domain identiﬁed from a phage display screen [9].
For clarity only a representative subset of peptides are used here (see [9] and [49]
for the full dataset analysis). Some conserved amino acids are highlighted with
different colors and bold font. (B) Consensus sequence corresponding to class II SH3
domains. (C) Single PWM. (D) Multiple PWMs. The PWMs are represented with
sequence logos. The height of each letter is proportional to the frequency of the
corresponding residue in the set of binding peptides. The two distinct speciﬁcity
patterns of C were identiﬁed with the MUSI software [54]. The curves on the right
illustrate the graphical analogy with energy landscapes. Estimates of the typical
dataset size allowing for different levels of details in speciﬁcity landscape analysis
are given for each model.
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ization, a domain can bind very speciﬁcally to one target, while it ap-
peared to be promiscuous in in vitro experiments with large peptide
libraries. In practice, when speaking about the ‘‘speciﬁcity of a do-
main’’, one often refers to the binding speciﬁcity towards the set of
all possible peptides, or the set of all peptides present in a proteome.
3.1. Computational models of binding speciﬁcity
Large-scale data about binding afﬁnity are becoming available
for a few selected systems, such as transcription factors binding
to short DNA sequences [2,39]. However, it is currently experimen-
tally unfeasible to generate large sets of such data for most peptide
recognition domains. To circumvent this limitation, computational
models have been developed that enable inferring binding speciﬁc-
ity from a limited set of experimental observations.
Consensus sequences, such as the well-known PPxY for class I
WW domains or PxxPx[R/K] for class II SH3 domains, have been
used to describe binding speciﬁcity. Consensus sequences are typ-
ically derived by aligning different peptides interacting with a gi-
ven domain and identifying recurring features in the alignment
(see Fig. 1, A and B). Large collections of such consensus sequences
for different domain families are now available in several dat-
abases [40,41]. From the computational point of view, this model
of speciﬁcity consists of a minimal number of parameters (1 or 0
for each amino acid at every position). It also enables rapid scan-
ning of protein sequences to ﬁnd sequence matches that are easily
recognizable just by looking at the sequence. Yet, it can fail to accu-
rately consider slightly less favorable residues at some position.
For instance, some SH3 domains, although preferentially binding
PxxP motifs ﬂanked by a basic residue, can still bind in the absence
of this residue with slightly weaker afﬁnity. Moreover, positions
represented with an x (i.e., described as completely unspeciﬁc) in
many cases still have weak preferences for some amino acids com-
pared to other ones (see Fig. 1). The amino acid preferences atthese positions are often important to distinguish domains of the
same family that have a conserved core binding motif, but display
differences in binding speciﬁcity of adjacent positions (see Fig. 2)
[12]. To overcome this issue, Position Weight Matrices (PWMs),
also called Position Speciﬁc Scoring Matrices or PSSMs, have been
introduced in the late 70s and early 80s [42–44] in the context of
biological sequence analysis. They have been widely used since
then to describe PRD binding speciﬁcity [12,13]. In this computa-
tional framework, a probability is assigned to every amino acid
at each position. These probabilities are typically computed as
the frequency of each amino acid at each position in a dataset of
aligned binding peptides (Fig. 1C). The PWM score of a peptide
can then be computed by multiplying the probabilities correspond-
ing to the different residues of the peptide at different positions.
Several web services, such as ScanSite [45], use PWMs to scan pro-
tein sequences and ﬁnd segments matching the speciﬁcity of dif-
ferent domains. This model of speciﬁcity can be readily
visualized with sequence logos [46] (Fig. 1C). In such representa-
tion, the height of each letter is proportional to the frequency
p(i) of the corresponding amino acid. The total height of the letters
at one position corresponds to the information content, deﬁned as
log2ð20Þ þ
P20
i¼1pðiÞ  log2ðpðiÞÞ. Fully speciﬁc positions have an
information content of log2ð20Þ  4:3, while completely random
positions have an information content of 0. The information con-
tent over different positions has often been used as way to quantify
the binding speciﬁcity of a domain, since alignments of peptides
binding to very speciﬁc domains display several positions with
high information content [9,12]. Sequence logos enable human
eyes to quickly grasp the main characteristics of domain speciﬁc-
ity. They are particularly useful when comparing speciﬁcity of dif-
ferent protein domains within the same family. For instance, Fig. 2
shows the binding speciﬁcity landscape of 54 human PDZ domains
[12]. The domains have been hierarchically clustered according to
their speciﬁcity patterns. Different speciﬁcity classes are clearly
visible, such as the well-known [T/S]xV motif characteristic of class
I PDZ domains. Moreover, within these classes, small differences in
binding speciﬁcity can be observed that help PDZ domains of the
same speciﬁcity class to differentiate from one another. PWMs
work well for a number of applications (e.g., prediction of new pro-
tein interactions [9], comparison between the binding speciﬁcity of
different PRDs [12,13]), even if they assume that each position
along the peptides contributes independently to the interactions.
They also provide the best possible computational model for many
experimental results, such as oriented peptide libraries, that by
construction do not give information about possible correlations
between different positions.
3.2. Correlations and multiple speciﬁcity
The assumption of positional independence that is made when
using single PWMs has been challenged in a number of recent
studies, suggesting that it may not hold true in several systems
[47–49]. Intuitively, one may imagine cases where two sidechains
at position a and b in a peptide point towards the same binding
pocket. Depending on the size of this pocket, a large bulky amino
acid (i) might be in general favorable at position a, but then require
a small one (j) at position b, or vice and versa. Mathematically
speaking, this would translate into values around 0.5 for the prob-
ability of these amino acids, paðiÞ and pbðjÞ, as well as for the prob-
ability of observing them together pa;bði; jÞ. Thus, the ratio pa;bði;jÞpaðiÞpbðjÞ
will be larger than one. One such example can be observed in
Fig. 1A. There, Arginine at position 3 is always found together with
Proline at position 9. Although in this case the two sidechains likely
do not point towards the same binding pocket, the ratio p3;9ðR;PÞp3ðRÞp9ðPÞ is
typically larger than one. This observation underlies the deﬁnition
Fig. 2. Global view of the speciﬁcity landscape of 54 human PDZ domains. For each domain a single PWM, displayed as a sequence logo, was built from the results of a phage
display screen [12]. The sequence logos were hierarchically clustered to highlight the different binding speciﬁcity classes observed among domains from the same family.
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and b, called mutual information: MI ¼P20i¼1
P20
j¼1pa;bði; jÞ
logð pa;bði;jÞpaðiÞpbðjÞÞ. Large values of this measure indicate that two posi-
tions display correlations or covariance in their amino acid distri-
butions. Reversely, values close to 0 indicate absence of
correlations (pa;bði; jÞ  paðiÞpbðjÞ). Mutual information, as well as
other derived versions such as normalized mutual information,
its P-value or its Z-score, have been used to identify correlations
in peptides interacting with PRDs from different families such as
SH3, WW or PDZ [49], or with major histocompatibility complex
[50].
In general, PRDs that display correlations in their ligands similar
to the example described before, or domains that have multiple
binding modes, are not well described with single PWMs. This
has led to different mathematical frameworks to describe their
binding speciﬁcity such as neural networks [48,50,51], Hidden
Markov Models [52], or support vector machines [53]. Recently,
we and others introduced the notion of multiple speciﬁcity land-
scapes [2,49,54]. This idea came from the observation that distinct
sequence patterns are often found in large datasets of peptides
interacting with the same domain. For instance, in Fig. 1A, the
majority of peptides follow the PxxPxR speciﬁcity of class II SH3 li-gands, but quite a few (manually positioned at the bottom of the
alignment and highlighted with the green Y) display a distinct
speciﬁcity. These different speciﬁcity patterns can be identiﬁed
by clustering the peptides interacting with a domain into different
subgroups [49] or by using the machine learning tools of mixture
models [54,55]. Each group of peptides is then described by a dif-
ferent PWM that is represented as a different sequence logo (see
Fig. 1D). Multiple speciﬁcity is particularly powerful to identify do-
mains with multiple binding modes. For instance, the Arginine res-
idues (R) highlighted in blue in the alignment of peptides binding
to Lsb1p SH3 domain in Fig. 1A are found on either side (but not on
both together) of a proline-rich region. In the case of SH3 domains,
this recalls a dual speciﬁcity (class I and II) corresponding to two
different orientations of the peptides in the binding site [7], as ob-
served for instance in structures of SRC SH3 domain [56]. In Fig. 1D,
the ﬁrst sequence logo corresponds to class II SH3 domains. The
second speciﬁcity pattern can be interpreted as a variant of class
I where the Arginine is found 4 residues upstream of a PxP motif.
Interestingly, this motif is observed in some proteins experimen-
tally found to interact with Lsb1p in a Yeast-two-Hybrid experi-
ment [9], such as Mca1p (YNRPVYPPP, residues 70–78). Multiple
speciﬁcity landscapes further bear analogy with the broad concept
of landscapes as mathematical functions (see the curves on the
2768 D. Gfeller / FEBS Letters 586 (2012) 2764–2772right of Fig. 1), such as free-energy landscapes used in protein
folding.
The observation of positional correlations and multiple speciﬁc-
ity raises the question about the spread of this phenomenon. In
general, we observed that domains with larger and more ﬂexible
binding sites are more likely to display multiple speciﬁcity. For in-
stance, multiple binding speciﬁcity has been found more often in
SH3 domains, many of which are known to accommodate different
binding modes, than in PDZ domains [49]. We also stress that
detecting correlations and multiple speciﬁcity is highly dependent
on the number of binding peptides and the coverage of the initial
peptide library. Indeed, the more observations of a pattern such
as R at position 3 and P at position 9 in Fig. 1A we have, the easier
it is to distinguish between real correlations and incidental occur-
rences. Similarly, multiple speciﬁcity can often only be detected
with at least a few tens of peptides. Thus it is likely that the spread
of this phenomenon is currently underestimated due to the lack of
enough experimental data for many domains. In our experience
with techniques to screen large peptide libraries such as phage dis-
play, we also observed that statistically signiﬁcant correlations are
found very often when the number of interacting peptides reaches
a few hundreds. With these large numbers of peptides, not all cor-
relations necessarily reﬂect multiple speciﬁcity. For instance, some
correlations correspond to slightly more favorable combinations of
two sidechains at two different positions, while other combina-
tions are not excluded. Nevertheless, it is clear that the larger the
sampling of the speciﬁcity space, the more likely one is to observe
different speciﬁcity patterns in binding peptide datasets.
3.3. Some limitations of complex speciﬁcity models
Detailed descriptions of binding speciﬁcity have the potential to
reveal interesting new features in protein interactions. However,
the promises offered by these recent computational models should
not lead us to believe that more complex models always give new
insights or better predictions [57]. Indeed several cases have been
reported where simpler models, such as consensus sequences or
single PWMs, are better to accurately represent available experi-
mental data [49,57]. In particular, the more complex a model, the
more difﬁcult it is to accurately estimate its parameters. It is also
known that different experimental techniques have different
biases. For instance, models built from genomic data might suffer
from biases due to common evolutionary origin of some sequences
that affect the statistics. Techniques involving competitive binding
assays like phage display tend to favor highest afﬁnity binders.
Hence, more detailed models of binding speciﬁcity may in some
cases provide an over-speciﬁc view that reﬂects inherent biases
in experimental techniques rather than biologically relevant prop-
erties [58]. However, despite these caveats, the current progresses
in experimental technologies offer promising opportunities for de-
tailed analysis of binding speciﬁcity that can lead to new biological
insights, provided researchers are aware of their limitations.
3.4. Global speciﬁcity models
The models of speciﬁcity landscapes described so far fall into
the category of so-called local models since a different model is re-
quired for every PRD in a domain family. In many cases, experi-
mental data are only available for a subset of domains. It is clear
that different protein domains within a family have many con-
served properties. Hence, a very attractive strategy is to leverage
these similarities to extrapolate from domains with available
experimental data to the rest of a domain family. This further al-
lows models of binding speciﬁcity to be transferred to orthologous
PRDs in other organisms. Several of these models have been re-
cently developed for some of the most studied PRD families. Thespeciﬁcity of the whole PDZ domain family has been predicted
using back-ﬁtting algorithms [59] or support vector machines
[60,61]. Knowledge-based energy models have been applied to
predict SH2–peptide interactions [62]. Neural networks have been
applied to analyze SH3 domain speciﬁcity [63]. A key feature of
these models is to identify correlations between residues in the
binding site of the domains and residues in the ligands [64].
3.5. Structure-based approaches
In parallel to statistical knowledge-based approaches using
experimental datasets of interacting peptides to describe binding
speciﬁcity, several structure-based strategies using binding free-
energy predictions have been developed to determine the speciﬁc-
ity of peptide recognition domains [65,66]. For instance, Smith and
Kortemme used PDZ domain structures to model thousands of dif-
ferent peptide sequences in the binding site of PDZ domains and
predict their binding free-energy [67]. A good agreement was
achieved between the speciﬁcity observed in experimental phage
display data [12] and the one predicted from the computational
screening. In silico mutagenesis scanning and structure-based pro-
tein interaction predictions have been applied to SH3 [68] and SH2
domains [69]. Similar techniques have also been applied for pep-
tide binding to major histocompatibility complex and new insights
on covariance between peptide residues could be derived from this
kind of analyses [70]. Structure-based approaches are powerful to
unravel some of the molecular mechanisms determining binding
speciﬁcity. Moreover, they can often accurately distinguish be-
tween residues that completely prevent binding (for instance be-
cause of large steric clashes) and residues that are simply not
very favorable. This kind of distinction can be more difﬁcult to
achieve from the analysis of binding peptides, since quantitative
negative (non-binding) data are often not available in sufﬁcient
quantity, although the situation is evolving with recent experimen-
tal techniques [13]. Conversely, structure-based techniques are
less amenable to predict ab initio ligands adopting other conforma-
tions or binding modes than the one found in available crystal
structures, since large rearrangements of backbone atoms are still
difﬁcult to describe without experimental data guiding the
modeling.4. Protein–protein interactions
4.1. Protein–protein interaction predictions
Better models of PRD binding speciﬁcity have important conse-
quences for our understanding of protein interactions. One of the
most common applications is in predicting protein–protein inter-
actions directly from protein sequences [59,61]. This strategy has
been successfully applied to several domain-mediated interac-
tions. The speciﬁcity of PDZ domains has been used to identify
interactions between human PDZ domains and several other pro-
teins. For instance, viral proteins binding to different PDZ domains
have been accurately predicted [12]. Mouse PDZ domain speciﬁcity
models were also used to predict new PDZ binding proteins and
these predictions could be extended to PDZ domains in other
organisms [59]. Combined experimental and computational strate-
gies have been elaborated for SH3 domain interaction predictions
in yeast [9,30]. In these studies, computational predictions based
on binding speciﬁcity were integrated with high-throughput pro-
tein–protein interactions detected with Yeast-two-Hybrid technol-
ogy. Focusing on more speciﬁc cases, interactions between ZO-2
and YAP2 in human could be predicted based on the speciﬁcity
of ZO-2 ﬁrst PDZ domain, revealing a new role of ZO-2 in YAP2
nuclear localization [71]. Similarly, TIAM1 PDZ speciﬁcity was used
Fig. 3. Non-canonical multiple speciﬁcity in PDZ domains. (A) The sequence logos
show the dual speciﬁcity observed for three different PDZ domains. Sequence logos
in the left column correspond to canonical PDZ speciﬁcity, while logos on the right
column correspond to non-canonical PDZ speciﬁcity. Data for the ﬁrst two domains
(DLG1 PDZ1 and MPD PDZ10) come from a phage display screen [12]. Peptides
interacting with ERBB2IP come from a SPOT assay [87] and have been manually
classiﬁed into two groups based on the presence or absence of a C-terminal
hydrophobic amino acid. (B) Structural modeling of the different speciﬁcities. The
experimental structure on the left shows the canonical binding mode of PDZ
domains for DLG3 PDZ1 (PDB: 2I1N). The structure on the right illustrates the
model proposed in [49] to explain the non-canonical speciﬁcity, based on a
structure of DLG2 PDZ1 (PDB: 2WL7) [86]. The green loop shows the predicted new
position of the carboxylate binding loop with extended ligands (in this model the
EETDIW peptide was used).
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[72]. Analysis of MAPK (JNK) docking site binding speciﬁcity was
also used to predict proteins interacting with MAPK8, MAPK9
and MAPK10 and many novel interactions could be experimentally
validated [73].
From these examples, it is clear that detailed analysis of binding
speciﬁcity is useful to guide biological experiments and enables ra-
pid identiﬁcation of the most promising candidates for experimen-
tal validations. However, despite some remarkable successes,
scanning proteomes with any model of binding speciﬁcity to ﬁnd
potential ligands of a domain often includes many false-positives
and false-negatives. Overlaps among predicted interactions and
large-scale experimental datasets of protein interactions are often
statistically signiﬁcant but not very large. Part of these discrepan-
cies comes from false-positives and false-negatives in experimen-
tal studies because of the difﬁculty to accurately detect transient
protein interactions such as those mediated by PRDs. However,
several differences observed between predictions and experiments
arise from the large number of hits that match a domain speciﬁcity
when scanning large datasets of protein sequences (e.g., whole
proteome). This is especially true for low speciﬁcity domains
whose speciﬁcity does not convey enough information to distin-
guish between true binders and incidental occurrences of a se-
quence motif in a proteome. This issue makes predictions of new
protein interactions much less accurate compared to, for instance,
the detection of domains in protein sequences. Therefore, protein
interaction predictions based on binding speciﬁcity should only
be used as a tool to generate new hypothesis and guide experimen-
tal investigations. Combining protein interaction predictions based
on binding speciﬁcity with other evidences such as disorder pre-
dictions, co-expression data or Gene Ontology similarity can also
help reducing the rate of false-positives and false-negatives
[74,75].
4.2. Binding site predictions
Another application of speciﬁcity landscapes, less prone to
false-positives, is to map known protein–protein interactions at
the binding site level. This can be successfully achieved when the
speciﬁcity of the different domains present in interacting proteins
are known or can be accurately predicted. For instance the differ-
ent proline-rich regions of yeast Las17p targeted by distinct SH3
domains could be accurately predicted based on the speciﬁcity of
these domains [30]. The two known binding sites of SRC SH3 do-
main in human ASAP1 protein have also been shown to match pre-
cisely the dual speciﬁcity of this domain [54]. This level of
understanding of protein interactions is key to answering many
important biological questions. It enables predicting the effect of
mutations, especially non-synonymous single nucleotide polymor-
phisms, on protein interactions. For instance, several RAF1 mutants
associated with Noonan and LEOPARD syndromes affect the bind-
ing motif targeted by YWHAZ 14-3-3 domain and are known to
prevent binding with YWHAZ [76]. Binding site information fur-
ther enables distinguishing between competing and concurrent
interactions in biological systems. This has wide consequences
for our understanding of regulatory mechanisms in signaling path-
ways. Indeed, two proteins competing for the same binding site
can directly regulate each other, which provides a molecular mech-
anism for cross-talks between signaling pathways. Competition
can arise either between different domains targeting the same pro-
tein segment or between different protein segments interacting
with the same domain. For instance CBLB was shown to act as a
negative regulator for signaling activities dependent on PAK activa-
tion by directly competing with the interaction between PAK and
ARHGEF6 (COOL-2) SH3 domain [77]. Large-scale in vitro screen-
ings of PRDs interactions with peptides coming from existing pro-teins also suggest several cases of possible competition [9,13].
However, the actual fraction of these cases that take place in vivo
is difﬁcult to estimate. Importantly, some apparently overlapping
binding sites are regulated by post-translational modiﬁcations
[78,79] that can switch them between different interacting do-
mains [80]. Binding site mapping via analysis of peptide recogni-
tion domain speciﬁcity has also been used recently to investigate
evolution and rewiring in protein interaction networks [81,82].
4.3. Structural analysis of binding speciﬁcity
Detailed analysis of speciﬁcity landscape is a powerful approach
to reveal new insights into structural features of protein interac-
tions. For instance, in [83], new structural models of peptides bind-
ing to kinases could be elaborated based on the results of oriented
peptide library screening. Large datasets of SH2 domain speciﬁcity
data have also been structurally modeled. This enabled a better
understanding of the structural basis of the selectivity for Aspara-
gine two amino acids downstream of the phosphorylated tyrosine
in a sub-class of SH2 domains [84]. Combining analysis of speciﬁc-
ity and structural modeling has further been used to predict posi-
tions in PRD sequences where single residue changes can switch
between different binding speciﬁcity [64,85]. Recently, using
2770 D. Gfeller / FEBS Letters 586 (2012) 2764–2772phage display data [12] and the multiple speciﬁcity approach of
[49] a new binding mode of DLG1 ﬁrst PDZ domain could be pre-
dicted. The non-canonical experimentally observed speciﬁcity
shown in Fig. 3A, right column, consists of a standard PDZ binding
motif (T-D-I for DLG1 PDZ1), ﬂanked with one additional residue at
the C-terminus (mostly W, Y or hydrophobic residues). This non-
canonical binding speciﬁcity could be modeled as a new binding
mode based on a recent crystal structure [86] and molecular mod-
eling analysis (Fig. 3B). In this model, the additional C-terminal res-
idue makes a salt-bridge interaction with a conserved Arginine,
while this salt-bridge is present via a water molecule in many
structures of PDZ domains bound to canonical ligands [11]. Inter-
estingly, a related multiple speciﬁcity pattern was also observed
for the tenth PDZ domain of human MPDZ [49], as well as in some
peptides binding to ERBB2IP PDZ domain in a SPOT assay [87] (see
Fig. 3A). These different examples highlight how detailed under-
standing of binding speciﬁcity in PRDs can lead to new structural
insights.
5. Beyond binding site speciﬁcity
Our understanding of PRDs and their binding speciﬁcities has
signiﬁcantly increased in recent years. Experimentally studying iso-
lated domains has proved crucial to reach a detailed understanding
of their properties [12] and enabledmapping protein interactions at
the binding site level [9,13,30]. However, growing evidence is
pointing to the importance of the domain context that can critically
inﬂuence peptide recognition domain interactions [88]. Multi-do-
main proteins often use more than one of their domains to target
different binding sites on the same protein, thereby increasing the
total afﬁnity as compared to single isolated domains. For instance,
both SRC SH2 and SH3 domains are required for tight association
with TNK2 [89]. Similarly, cooperativity between PDZ and SH3 do-
mains was recently observed in crystal structures of ZO-1 in com-
plex with JAM-A C-terminal peptide [90]. Linker segments
between domains or other extra-domain regions are also observed
to play an increasingly important role in modulating the properties
of single domains [91,92]. For example, the afﬁnity of the third PDZ
domain of PSD-95 for CRIPT C-terminal peptide has been shown to
increase by 20 folds in the presence of a C-terminal helix that is not
part of the standard domain deﬁnition [93,94].
The biological context also plays an important role in modulat-
ing protein interactions mediated by peptide recognition domains.
It is clear that not all proteins are expressed at the same place and
at the same time. As such, speciﬁc molecular recognition between
a domain and its substrate can be achieved by ensuring that two
proteins are selectively found together at the same time, in the
same cell and in the same microscopic environment, while other
potential competitors are not. The extent of this phenomenon is
still difﬁcult to estimate accurately at a genome-wide scale with
today’s data about biological systems. However, several examples
support this idea of combined positive and negative selection in
protein interactions by genomic [95,96], spatial [83] or temporal
context. Scaffold proteins play very important roles in this process
by increasing the local concentration of two interacting proteins,
while their absolute concentration in cells would have been too
low for them to bind [97].
6. Conclusion and outlook
Knowledge of binding speciﬁcity is crucial to understand the
underlying mechanisms enabling biological systems to accurately
and efﬁciently carry out multiple tasks under crowded cellular
environments. Determining the exact sequence patterns recog-
nized by peptide recognition domains is a key step in this directionand is useful to better predict their interactions. Detailed models of
speciﬁcity landscapes can further guide our biological and struc-
tural understanding of protein interactions, as we have seen in this
review.
Clearly, the availability of large experimental datasets of inter-
acting peptides is and will increasingly be a major driving force
to enhance our understanding of protein interactions mediated
by PRDs. In this respect, we envision that peptide screening tech-
niques like phage display have an important potential to reveal no-
vel aspects of PRD speciﬁcity and interactions. Structure-based
approaches provide complementary information to high-through-
put experimental screening. As such, we expect that, from the
computational point of view, combining statistical knowledge-
based approaches to analyze binding speciﬁcity data together with
structural modeling will prove very useful to enhance our under-
standing of peptide recognition domain speciﬁcity landscapes.
Ultimately, new insights into protein–protein interactions
should translate into new tools to interfere with these interactions.
Recent progresses in this direction have shown that detailed
understanding of speciﬁcity landscapes can help identifying in sil-
ico new ligands inhibiting protein–protein interactions [98], using
for instance structure-based design [99] or peptido-mimetics strat-
egies [100,101]. However, despite these promising advances, it is
still a signiﬁcant challenge to translate our understanding of bind-
ing speciﬁcity into new molecules targeting PRD mediated protein
interactions. This challenging task will require combining experi-
mental screening technologies together with structural and bioin-
formatics analysis. Efﬁcient tools to leverage the large amount of
information currently available about binding speciﬁcity land-
scapes will play an important role to guide the design of new mol-
ecules selectively inhibiting protein–protein interactions.
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